Home > Financial Ratios > TTK HEALTHCARE

TTK HEALTHCARE
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for TTK HEALTHCARE
Please provide your vote to see the results

TTK HEALTHCARE Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 6.1525.42108.7630.47-21.08

What is the latest Core EBITDA Growth ratio of TTK HEALTHCARE ?

The latest Core EBITDA Growth ratio of TTK HEALTHCARE is 6.15 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar20256.15
Mar202425.42
Mar2023108.76
Mar202230.47
Mar2021-21.08

How is Core EBITDA Growth of TTK HEALTHCARE Trending?

Years Core EBITDA Growth % Change
Mar2025 6.15
-75.81
Mar2024 25.42
-76.63
Mar2023 108.76
256.94
Mar2022 30.47
Positive
Mar2021 -21.08 -

Other Financial Ratios of TTK HEALTHCARE


Compare Core EBITDA Growth ratio of peers of TTK HEALTHCARE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TTK HEALTHCARE ₹1,808.0 Cr -0.4% 4.6% -12.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹402,320.0 Cr 0.9% -0.1% 10.9% Stock Analytics
DIVIS LABORATORIES ₹180,823.0 Cr 3.7% 3% 46.5% Stock Analytics
CIPLA ₹121,591.0 Cr 0.2% 2.8% 1.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹115,400.0 Cr 7.3% 7.4% 19.8% Stock Analytics
DR REDDYS LABORATORIES ₹107,135.0 Cr -4% 2.6% 7.2% Stock Analytics


TTK HEALTHCARE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TTK HEALTHCARE

-0.4%

4.6%

-12.4%

SENSEX

2.1%

2.4%

7.1%


You may also like the below Video Courses